SS Innovations International, Inc. — Cyborg Score 6/10
Solid
Surgical robotic systems
Strategic Profile
The company uplisted to Nasdaq Capital Market in April 2025 and continues trading under the ticker SSII. SS Innovations is pursuing global expansion beyond India into Nepal, Ecuador, Guatemala, the Philippines, Indonesia, Sri Lanka and Ukraine, while pursuing EU CE Mark and U.S. FDA approval for its SSi Mantra surgical robotic system, anticipated in late 2025 and early 2026 respectively. The company expects to report full year 2025 revenue of approximately $43.0 million, up 108% from $20.6 million in 2024.
Cyborg Score Rationale
SSII demonstrates strong revenue growth (108% YoY for 2025) and successful clinical validation of its core technology. However, the company faces execution risks with regulatory approvals pending, emerging competitive pressures in surgical robotics, and high insider ownership (76.5%) raising governance concerns. Stock performance has been challenged, down 58.56% over the past year.
Top Insights
Completed human factors validation study for SSi Mantra at Johns Hopkins Hospital in September 2025.
Showcased multiple innovations at Global Multi-Specialty Robotic Surgery Conference (SMRSC 2026) including SSi Vimana Aero Drone System, SSi Avtara Humanoid Surgical Platform, and SSi Operion Mobile Operating Room.
Q4 2025 revenue expected at approximately $15.0 million, up 85% from $8.1 million in Q4 2024.
Company filed follow-on equity offering of $49.999997 million to support growth initiatives.
Named Competitors
da Vinci Surgical System — Leading minimally invasive robotic surgery platform
Vicarious Surgical Platform — AI-powered robotic surgery platform
Allurion Minimally Invasive Procedures — Minimally invasive medical devices
Recent Developments
(June 2026) Hosted Global Multi-Specialty Robotic Surgery Conference (SMRSC 2026) in New Delhi showcasing cutting-edge surgical robotic technologies
(June 2026) Filed follow-on equity offering of approximately $50 million
(September 2025) Completed human factors validation study for SSi Mantra at Johns Hopkins Hospital
(April 2025) Uplisted to Nasdaq Capital Market under ticker SSII
Open the full interactive SS Innovations International, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.